GLUE Operating Income Growth

Monte Rosa Therapeutics Inc · Operating Income Growth

GLUE logo

GLUE Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-1315.68%
GLUE TTM Operating Income YoY % (-160.19% → -1315.68%)
High-resolution chart · PNG

GLUE operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Monte Rosa Therapeutics Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
-1,315.6829%
-6,864.6783%
33.169%
106.5987%
110.7295%
98.5215%
43.4014%
8.4846%
-5.357%
-17.703%
-27.519%
-36.4584%
-39.6073%
-42.7883%
-54.1999%
-68.1268%
-97.685%
-143.2571%
-160.1906%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.